Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $20.42 -2.25%
EPS Growth %: -25.0%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -25.0%
Financial Fact:
Comprehensive income (loss): 9.26M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Activist Jana Partners calls for Six Flags sale - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
